These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19015227)

  • 41. Clinical features of CIDP with LM1-associated antibodies.
    Kuwahara M; Suzuki H; Samukawa M; Hamada Y; Takada K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):573-5. PubMed ID: 23138763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.
    Mathey EK; Park SB; Hughes RA; Pollard JD; Armati PJ; Barnett MH; Taylor BV; Dyck PJ; Kiernan MC; Lin CS
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):973-85. PubMed ID: 25677463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
    Tagawa Y; Yuki N; Hirata K
    Muscle Nerve; 2000 Jun; 23(6):895-9. PubMed ID: 10842265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
    Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
    Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
    Illa I
    J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.
    Diederich JM; Staudt M; Meisel C; Hahn K; Meinl E; Meisel A; Klehmet J
    Front Neurol; 2018; 9():171. PubMed ID: 29615965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I
    Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
    Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptides From the Variable Domain of Immunoglobulin G as Biomarkers in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Godelaine J; Chitale Y; De Moor B; Mathieu C; Ancheva L; Van Damme P; Claeys KG; Bossuyt X; Carpentier S; Poesen K
    Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37640545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies.
    Nobile-Orazio E; Giannotta C
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():18-23. PubMed ID: 21696492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Faucard R; Madeira A; Gehin N; Authier FJ; Panaite PA; Lesage C; Burgelin I; Bertel M; Bernard C; Curtin F; Lang AB; Steck AJ; Perron H; Kuntzer T; Créange A
    EBioMedicine; 2016 Apr; 6():190-198. PubMed ID: 27211560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
    Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
    J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.
    Ogata H; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Isobe N; Kira JI
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2304-2316. PubMed ID: 31657126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CIDP, CMT1B, or CMT1B plus CIDP?
    Cardellini D; Zanette G; Taioli F; Bertolasi L; Ferrari S; Cavallaro T; Fabrizi GM
    Neurol Sci; 2021 Mar; 42(3):1127-1130. PubMed ID: 33070202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
    Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
    Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients.
    Rentzos M; Angeli AV; Rombos A; Kyrozis A; Nikolaou C; Zouvelou V; Dimitriou A; Zoga M; Evangelopoulos ME; Tsatsi A; Tsoutsou A; Evdokimidis I
    Neurol Res; 2012 Nov; 34(9):842-6. PubMed ID: 22947427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents.
    Toyka KV; Gold R
    Neurology; 2003 Apr; 60(8 Suppl 3):S2-7. PubMed ID: 12707416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies Against Dihydrolipoamide S-Acetyltransferase in Immune-Mediated Neuropathies.
    Fukami Y; Iijima M; Koike HH; Yagi S; Furukawa S; Mouri N; Ouchida J; Murakami A; Iida M; Yokoi S; Hashizume A; Iguchi Y; Imagama S; Katsuno M
    Neurol Neuroimmunol Neuroinflamm; 2024 Mar; 11(2):e200199. PubMed ID: 38181320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Humoral antibodies in immune mediated neuropathy].
    Saito T
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1364-7. PubMed ID: 1966017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Myelin basic protein, anti-sulfated glucuronyl paragloboside (SGPG) antibody and anti-P0 antibody].
    Ohta M; Ohta K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():641-4. PubMed ID: 20942152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.